Australians with metabolic dysfunction-associated steatotic liver disease have a twofold increase in the incidence of cancer.
Elizabeth E PowellShruti RocheBabak SarrafGunter F HartelRichard SkoienBarbara A LeggettJames O'BeirnePatricia Casarolli ValeryPublished in: JGH open : an open access journal of gastroenterology and hepatology (2024)
Our findings will help to raise awareness among clinicians about the importance of cancer vigilance in this patient group.